The Office of the U.S. Trade Representative has extended from Nov. 14 through Nov. 30 exclusions from the Section 301 additional tariffs on imports from China for 99 medical care products needed to address the COVID-19 pandemic. USTR will then extend 81 of those exclusions through May 31, 2022, while the remaining 18 will no longer be available as of Dec. 1, 2021.

These exclusions are available for any product that meets the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request. Click here for a list of the 99 current exclusions; click here for a list of the 81 exclusions being extended through May 31.

In the meantime, USTR is accepting through Dec. 1 comments on whether China Section 301 tariff exclusions that expired Dec. 31, 2020, should be renewed and, if so, for how long. Any exclusions that are eventually renewed will be retroactive to Oct. 12, 2021.

For USTR to renew an exclusion it will be necessary for importers to again provide concise, yet compelling, information demonstrating the need to source covered products from China, the lack of domestic alternatives, and the impact on the importer. ST&R successfully obtained section 301 tariff exclusions during the last process and can assist your company in petitioning for a renewal of your exclusion now. 

For other exclusions, we invite you to join our advocacy efforts to press for a full reopening of the exclusion process and a renewal of any previously expired exclusions. 

For more information, please contact us at

Click here for more information on strategies importers can use to mitigate the impact of Section 301 and other tariffs.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.